[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D004206:Disopyramide / Q000627:therapeutic use; D004562:Electrocardiography; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D011405:Propafenone; D011427:Propiophenones / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011427:Propiophenones; D011405:Propafenone; D008012:Lidocaine; D014700:Verapamil; D004206:Disopyramide; D011802:Quinidine; D000638:Amiodarone
Effets des anti-arythmiques sur la fréquence cardiaque. Signification et intérêt.